STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trialMatthew J. Reilley, David S. Hong, Razelle Kurzrock et al.|Journal for ImmunoTherapy of Cancer|2018Cited by 286
Identification of Compounds with Nanomolar Binding Affinity for Checkpoint Kinase-1 Using Knowledge-Based Virtual ScreeningPaul D. Lyne, Susan Ashwell, Peter W. Kenny et al.|Journal of Medicinal Chemistry|2004Cited by 112